Mirko Faber

5.9k total citations
67 papers, 2.5k citations indexed

About

Mirko Faber is a scholar working on Infectious Diseases, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mirko Faber has authored 67 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 22 papers in Hepatology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mirko Faber's work include Viral gastroenteritis research and epidemiology (26 papers), Hepatitis Viruses Studies and Epidemiology (22 papers) and Viral Infections and Vectors (9 papers). Mirko Faber is often cited by papers focused on Viral gastroenteritis research and epidemiology (26 papers), Hepatitis Viruses Studies and Epidemiology (22 papers) and Viral Infections and Vectors (9 papers). Mirko Faber collaborates with scholars based in Germany, Sweden and Netherlands. Mirko Faber's co-authors include Klaus Stark, Uwe Fuhr, Alexander Jetter, Christina Frank, Jürgen J. Wenzel, Michael Thamm, Michael Höhle, Dirk Werber, Rainer G. Ulrich and Ruth Zimmermann and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Mirko Faber

64 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirko Faber Germany 26 1.1k 877 471 229 211 67 2.5k
Robin McKenzie United States 24 628 0.6× 278 0.3× 572 1.2× 269 1.2× 169 0.8× 41 2.0k
Ashish Bavdekar India 30 588 0.5× 248 0.3× 695 1.5× 283 1.2× 435 2.1× 115 2.9k
Masud Alam United States 25 1.6k 1.4× 194 0.2× 445 0.9× 388 1.7× 116 0.5× 61 2.7k
Jean‐François Rossignol United States 36 1.9k 1.7× 479 0.5× 1.3k 2.7× 441 1.9× 277 1.3× 79 3.8k
Latif Gachkar Iran 24 341 0.3× 343 0.4× 469 1.0× 212 0.9× 98 0.5× 181 2.2k
Samer S. El‐Kamary United States 29 630 0.6× 1.1k 1.3× 1.3k 2.8× 210 0.9× 270 1.3× 74 2.6k
Emilia Anis Israel 22 1.6k 1.4× 126 0.1× 539 1.1× 154 0.7× 239 1.1× 79 2.5k
Thomas Hennessy United States 24 711 0.6× 375 0.4× 986 2.1× 280 1.2× 242 1.1× 61 2.4k
Lei Jia China 24 630 0.6× 117 0.1× 244 0.5× 276 1.2× 63 0.3× 84 1.7k
Zhi‐Dong Jiang United States 27 1.2k 1.0× 377 0.4× 469 1.0× 463 2.0× 606 2.9× 75 2.4k

Countries citing papers authored by Mirko Faber

Since Specialization
Citations

This map shows the geographic impact of Mirko Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Faber more than expected).

Fields of papers citing papers by Mirko Faber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirko Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Faber. The network helps show where Mirko Faber may publish in the future.

Co-authorship network of co-authors of Mirko Faber

This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Faber. A scholar is included among the top collaborators of Mirko Faber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Faber. Mirko Faber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chhabra, Preeti, Shan S. Wong, Sandra Niendorf, et al.. (2024). Increased circulation of GII.17 noroviruses, six European countries and the United States, 2023 to 2024. Eurosurveillance. 29(39). 13 indexed citations
2.
Hommes, Franziska, et al.. (2024). Autochthonous and imported giardiasis cases: An analysis of two decades of national surveillance data, Germany, 2002 to 2021. Eurosurveillance. 29(20). 1 indexed citations
3.
Koch, Nadine, Friederike Bachmann, Evelyn Seelow, et al.. (2023). Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients. Pathogens. 12(6). 850–850. 2 indexed citations
4.
Schemmerer, Mathias, Jürgen J. Wenzel, Klaus Stark, & Mirko Faber. (2022). Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019. Emerging Microbes & Infections. 11(1). 1754–1763. 26 indexed citations
5.
Faber, Mirko, et al.. (2022). No Evidence for Orthohepevirus C in Archived Human Samples in Germany, 2000–2020. Viruses. 14(4). 742–742. 10 indexed citations
6.
Faber, Mirko, Klaus Stark, Martha Holtfreter, et al.. (2021). Suitability of current typing procedures to identify epidemiologically linked human Giardia duodenalis isolates. PLoS neglected tropical diseases. 15(3). e0009277–e0009277. 21 indexed citations
7.
Faber, Mirko, et al.. (2020). Umweltmedizinische Versorgungssituation von Patientinnen und Patienten in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(2). 242–250. 1 indexed citations
8.
Appelt, Sandra, et al.. (2020). Francisella tularensis Subspecies holarctica and Tularemia in Germany. Microorganisms. 8(9). 1448–1448. 24 indexed citations
9.
Zimmermann, Ruth, Mirko Faber, Sandra Dudareva, et al.. (2020). Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions. International Journal of Infectious Diseases. 103. 146–153. 16 indexed citations
10.
Akanbi, Olusola Anuoluwapo, et al.. (2020). Hepatitis E Virus Seroprevalence and Associated Risk Factors in Apparently Healthy Individuals from Osun State, Nigeria. Pathogens. 9(5). 392–392. 9 indexed citations
11.
Stark, Klaus, et al.. (2020). Epidemiological trends of notified human brucellosis in Germany, 2006–2018. International Journal of Infectious Diseases. 93. 353–358. 21 indexed citations
12.
Niendorf, Sandra, et al.. (2020). Diversity of Noroviruses throughout Outbreaks in Germany 2018. Viruses. 12(10). 1157–1157. 10 indexed citations
13.
Michaelis, Kai, Christina Poethko‐Müller, Ronny Kuhnert, Klaus Stark, & Mirko Faber. (2018). Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany. Scientific Reports. 8(1). 16696–16696. 11 indexed citations
14.
Faber, Mirko, Niklas Willrich, Mathias Schemmerer, et al.. (2018). Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. Journal of Viral Hepatitis. 25(6). 752–758. 57 indexed citations
15.
Thomas, Stephanie Margarete, Nils Tjaden, Christina Frank, et al.. (2018). Areas with High Hazard Potential for Autochthonous Transmission of Aedes albopictus-Associated Arboviruses in Germany. International Journal of Environmental Research and Public Health. 15(6). 1270–1270. 15 indexed citations
17.
Faber, Mirko, Hanna Christiansen, H Oppermann, et al.. (2009). Untersuchungen zu einem familiären Cluster von Infektionen durch Influenza A/H1N1 in Deutschland, 2009. Das Gesundheitswesen. 71(10). 675–679. 2 indexed citations
18.
Faber, Mirko. (2004). Time response of cytochrome P450 1A2 activity on cessation of heavy smoking*1. Clinical Pharmacology & Therapeutics. 76(2). 178–184. 172 indexed citations
19.
Lüttichau, Hans Rudolf, et al.. (1999). [An outbreak of Pontiac fever among children and adults following a whirlpool bath].. PubMed. 161(23). 3458–62. 3 indexed citations
20.
Fincham, J.E., Walter F. O. Marasas, Jantjie Taljaard, et al.. (1992). Atherogenic effects in a non-human primate of cultures added to a carbohydrate diet. Atherosclerosis. 94(1). 13–25. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026